Cargando…

The Patient Health Questionnaire (PHQ-9) as a tool to screen for depression in people with multiple sclerosis: a cross-sectional validation study

BACKGROUND: Depression has a point prevalence of 25% and lifetime prevalence of 50% in people with multiple sclerosis (pwMS). Due to accessibility and brevity, the 9-item Patient Health Questionnaire (PHQ-9) may be a useful tool in clinical practice for screening and monitoring of depressive symptom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beswick, Emily, Quigley, Suzanne, Macdonald, Pamela, Patrick, Sarah, Colville, Shuna, Chandran, Siddharthan, Connick, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706934/ https://www.ncbi.nlm.nih.gov/pubmed/36443880 http://dx.doi.org/10.1186/s40359-022-00949-8

Ejemplares similares

Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review
por: Patrick, Sarah, et al.
Publicado: (2019)

Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine
por: Seo, Jong-Geun, et al.
Publicado: (2015)

Depression screening in HIV-positive Tanzanian adults: comparing the PHQ-2, PHQ-9 and WHO-5 questionnaires
por: Nolan, C. P., et al.
Publicado: (2018)

The reliability and validity of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with infertility
por: Maroufizadeh, Saman, et al.
Publicado: (2019)

PHQ-9 and PHQ-2 for Screening Depression in Chinese Rural Elderly
por: Liu, Zi-wei, et al.
Publicado: (2016)

Comparison of PHQ-9 and PHQ-2 as Screening Tools for Depression and School Related Stress in Inner City Adolescents
por: Anand, Paridhi, et al.
Publicado: (2021)

Mental Health during fatherhoood. Biopsychosocial aspects and questionnaire for depression PHQ9
por: Solis Correa, M. O., et al.
Publicado: (2023)

The Validity and Reliability of the Sinhala Translation of the Patient Health Questionnaire (PHQ-9) and PHQ-2 Screener
por: Hanwella, Raveen, et al.
Publicado: (2014)

Validity of the patient health questionnaires (phq-2 and phq-9) for screening depression among human immunodeficiency virus patients in Lahore, Pakistan
por: Junaid, Khunsa, et al.
Publicado: (2022)

The diagnostic accuracy of the Patient Health Questionnaire-2 (PHQ-2), Patient Health Questionnaire-8 (PHQ-8), and Patient Health Questionnaire-9 (PHQ-9) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses
por: Thombs, Brett D, et al.
Publicado: (2014)

Validation of the Patient Health Questionnaire (PHQ-9) as a screening tool for depression in pregnant women: Afaan Oromo version
por: Woldetensay, Yitbarek Kidane, et al.
Publicado: (2018)

National audit of cognitive assessment in people with pwMND A national audit of cognitive assessment in people with motor neurone disease (pwMND) in Scotland
por: Stavrou, Maria, et al.
Publicado: (2020)

Validation and calibration of the patient health questionnaire (PHQ-9) in Argentina
por: Urtasun, María, et al.
Publicado: (2019)

Validity and Utility of the Patient Health Questionnaire (PHQ)‐2 and PHQ‐9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross‐Sectional Study
por: Arrieta, Jafet, et al.
Publicado: (2017)

Validity of the PHQ-9 and PHQ-2 to screen for depression in nationwide primary care population in Latvia
por: Rancans, Elmars, et al.
Publicado: (2018)

Utilizing a Personal Smartphone Custom App to Assess the Patient Health Questionnaire-9 (PHQ-9) Depressive Symptoms in Patients With Major Depressive Disorder
por: Torous, John, et al.
Publicado: (2015)

Utility of PHQ-2, PHQ-8 and PHQ-9 for detecting major depression in primary health care: a validation study in Spain
por: Gómez-Gómez, Irene, et al.
Publicado: (2023)

Translating measurement into practice: Brazilian norms for depressive symptom assessment with the Patient Health Questionnaire (PHQ-9)
por: Damiano, Rodolfo Furlan, et al.
Publicado: (2023)

Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies
por: Mitchell, Alex J., et al.
Publicado: (2016)

Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
por: Jayaprakash, Kiran, et al.
Publicado: (2020)

Comparison of the Usefulness of the PHQ-8 and PHQ-9 for Screening for Major Depressive Disorder: Analysis of Psychiatric Outpatient Data
por: Shin, Cheolmin, et al.
Publicado: (2019)

Screening for Major Depressive Disorder with the Patient Health Questionnaire (PHQ-9 and PHQ-2) in an Outpatient Clinic Staffed by Primary Care Physicians in Japan: A Case Control Study
por: Suzuki, Keiko, et al.
Publicado: (2015)

Depressive Symptomatology among Norwegian Adolescent Boys and Girls: The Patient Health Questionnaire-9 (PHQ-9) Psychometric Properties and Correlates
por: Burdzovic Andreas, Jasmina, et al.
Publicado: (2017)

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis
por: Levis, Brooke, et al.
Publicado: (2019)

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis
Publicado: (2019)

Interformat reliability of the patient health questionnaire: Validation of the computerized version of the PHQ-9
por: Erbe, Doris, et al.
Publicado: (2016)

Development and validation of the Maudsley Modified Patient Health Questionnaire (MM-PHQ-9)
por: Harrison, Phillippa, et al.
Publicado: (2021)

Psychometrics of the Patient Health Questionnaire (PHQ-9) in Uganda: A Systematic Review
por: Kaggwa, Mark Mohan, et al.
Publicado: (2022)

Close, but not close enough: Brazilian norms for the Patient Health Questionnaire (PHQ-9)
por: Wang, Yuan-Pang, et al.
Publicado: (2023)

The validity and reliability of the PHQ-9 in screening for post-stroke depression
por: Dajpratham, Piyapat, et al.
Publicado: (2020)

The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis
por: Mollison, Daisy, et al.
Publicado: (2017)

Sensitivity and specificity of the Patient Health Questionnaire (PHQ-9, PHQ-8, PHQ-2) and General Anxiety Disorder scale (GAD-7, GAD-2) for depression and anxiety diagnosis: a cross-sectional study in a Peruvian hospital population
por: Villarreal-Zegarra, David, et al.
Publicado: (2023)

Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran
por: Khamseh, Mohammad E, et al.
Publicado: (2011)

People with diabetes need a lower cut-off than others for depression screening with PHQ-9
por: Cichoń, Ewelina, et al.
Publicado: (2020)

Validity and item response theory properties of the Patient Health Questionnaire-9 for primary care depression screening in Mozambique (PHQ-9-MZ)
por: Cumbe, Vasco F. J., et al.
Publicado: (2020)

Detection of depression in low resource settings: validation of the Patient Health Questionnaire (PHQ-9) and cultural concepts of distress in Nepal
por: Kohrt, Brandon A., et al.
Publicado: (2016)

Use of the Patient Health Questionnaire (PHQ-9) in Practice: Interactions between patients and physicians
por: Ford, Joseph, et al.
Publicado: (2020)

Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis
por: Round, Jessica M., et al.
Publicado: (2020)

Adaptation, Validity, and Reliability of the Patient Health Questionnaire (PHQ-9) in the Kurdistan Region of Iraq
por: Policastro, Francesca, et al.
Publicado: (2023)

Assessment of depression severity with the PHQ-9 in cancer patients and in the general population
por: Hinz, Andreas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hn0irfh5vtg4sm5juf0rneock3